[1]
“Cost-effectiveness of ramipril in patients at high risk for cardiovascular events: a Swiss perspective”, Swiss Med Wkly, vol. 134, no. 2728, pp. 399–405, Jul. 2004, doi: 10.4414/smw.2004.10498.